Post-Market Clinical Survey of Clareon® IOL AutonoMe™ in Japanese Subjects
NCT ID: NCT03824028
Last Updated: 2021-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
384 participants
OBSERVATIONAL
2019-02-10
2020-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-Market Clinical Investigation of the Clareon® IOL
NCT03316885
Clinical Investigation of the Clareon® Intraocular Lens (IOL)
NCT03170154
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
NCT07161635
Clareon Toric vs Eyhance Toric
NCT05481125
Clareon Toric Study (T2-T9)
NCT06285695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clareon IOL AutonoMe
Prior implantation with Clareon intraocular lenses (IOLs) using the Clareon® IOL AutonoMe™ automated preloaded delivery system
Clareon® IOL AutonoMe™ automated preloaded delivery system
Disposable injector preloaded with the Clareon IOL for precise IOL insertion during cataract surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clareon® IOL AutonoMe™ automated preloaded delivery system
Disposable injector preloaded with the Clareon IOL for precise IOL insertion during cataract surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prior diagnosis of age-related cataracts.
* Prior cataract surgery with implantation of Clareon IOL in the capsular bag by AutonoMeâ„¢.
* No ophthalmic disease which might affect visual acuity.
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alcon Research
Role: STUDY_DIRECTOR
Alcon Japan, Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Investigative Site
Yokohama, Kanagawa, Japan
Alcon Investigative Site
Yokkaichi, Mie-ken, Japan
Alcon Investigative Site
Hashimoto, Wakayama, Japan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Oshika T, Sasaki N; Clinical Study Group on New Intraocular Lens and Delivery System. One-year multicenter evaluation of a new hydrophobic acrylic intraocular lens with hydroxyethyl methacrylate in an automated preloaded delivery system. J Cataract Refract Surg. 2022 Mar 1;48(3):275-279. doi: 10.1097/j.jcrs.0000000000000746.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILM171-P001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.